Increasing investment and innovation in photonics in medicine – biophotonics – is part of the move away from invasive methods of patient care and towards non-invasive methods. So says Antanus Laurutis, CEO of Vilnius, Lithuania-based Altechna.
A market analysis by Grandviewresearch predicts that the $61bn biophotonics market (2022) will grow by 10.3% CAGR until 2030. The...